Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis
- 1 April 1986
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 99 (1) , 108-118
- https://doi.org/10.1016/0008-8749(86)90220-0
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Comparison of murine lymphokine-activated killer cells, natural killer cells, and cytotoxic T lymphocytesCellular Immunology, 1985
- In vitro and In vivo antitumor activity of lymphokine‐induced cytotoxic cellsInternational Journal of Cancer, 1985
- Changes in the host natural killer cell population in mice during tumor developmentCellular Immunology, 1985
- Changes in the host natural killer cell population in mice during tumor developmentCellular Immunology, 1985
- Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent originInternational Journal of Cancer, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- TUMOR IMMUNOLOGY—THREE DECADES IN REVIEWAnnual Review of Microbiology, 1983
- Tumor-associated prostaglandins in patients with primary breast cancer: Relationship to clinical parametersBreast Cancer Research and Treatment, 1982
- Prostaglandin Synthetase Inhibitors as Immunoadjuvants in the Treatment of CancerJournal of Immunopharmacology, 1980
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976